Cannabis Science, Inc. (CBIS) Appoints Dr. Jermane Bond, Noted Research Scientist, to Its Scientific Advisory Board
Cannabis Science, Inc. (CBIS), a U.S. company specializing in the development of cannabinoid-based medicines, is pleased to announce the Company has appointed Dr. Jermane Bond, a noted research scientist, to its Scientific Advisory Board (SAB). Dr. Bond has over 15 years of research and public health experience and is... Read more
MassRoots, Inc. (MSRT) Expanding Technology Offerings to Regulated Dispensaries in California
MassRoots, Inc. (“MassRoots” or the “Company”) (MSRT), one of the leading technology platforms for the regulated cannabis industry, is pleased to announce it is expanding its paid offerings to licensed dispensaries in the Californian market to enable them to more effectively offer time-limited deals to consumers. According to New... Read more
Pure Global Cannabis Inc. (PURE) (PRCNF) Announces Listing on Frankfurt Stock Exchange
Pure Global Cannabis Inc. (TSX.V:PURE; OTC: PRCNF; FRA:1QS)  (the “Company” or “Pure Global” or “PURE“), a vertically integrated growth-oriented life sciences cannabis company, announced today that its shares are now listed on the Frankfurt Stock Exchange under the “WKN:A2JQ26” and the ticker symbol “1QS”. The company’s shares continue to be listed on the... Read more
Namaste Technologies Inc.(NXTTF) signs binding terms sheet to acquire UK-based licensed pharmaceutical distribution company
Namaste Technologies Inc. (“Namaste” or the “Company”) (TSXV:N.V) (M5BQ.F) (NXTTF) is pleased to announce that the Company’s wholly-owned subsidiary, Namaste Bahamas Inc. (“Namaste Bahamas”), has signed a Binding Terms Sheet (“Terms Sheet”) to acquire all of the issued and outstanding shares of UK-Based AF Trading Ltd. (operating as “Access... Read more
GT Biopharma Inc. (GTBP) Announces Postive Results For Two Next Generation Trikes In Solid Tumors
GT Biopharma Inc. (GTBP) and (Euronext Paris: GTBP) announced today the positive results for two next generation Trispecific Killer Engagers (TriKEs) in solid tumors. These efforts were headed by Dr. Daniel Vallera, Director, Section of Molecular Cancer Therapeutics and Dr. Martin Felices, Co-Director of the Translational Therapy Laboratory at... Read more
CannAwake Corporation (CANX) and American Green Complete Purchase of Nipton Solar Facility
American Green, Inc. (ERBB:OTC) and CannAwake Corporation (CANX:OTCQB) are pleased to announce that they have completed the purchase of the solar power generating station in Nipton, California. Scott Stoegbauer, CannAwake’s president, stated, “After months of very productive negotiations, I am proud to announce that we have finally closed on the purchase... Read more
Marijuana Stocks Continue to Boom as Summer Comes to an End
The summer of this year has been hailed as one of the most important summers for the cannabis industry since its began. With new investments in the cannabis space and the addition of alcohol distributors and producers getting involved in the weed industry, it seems as though now is... Read more
These Marijuana Companies Are Still Under the Radar
The cannabis market has been quite lucrative for some time now, but new additions to legal measures around the world and the changing public perception of cannabis have all contributed to a fast-paced market growth. As new companies continue to innovate, it seems as though cannabis is the market... Read more
Integrated Cannabis Company, Inc. (ICNAF) Develops THC-Infused Spray Product
Integrated Cannabis Company, Inc. (CSE: ICAN, OTCQB: ICNAF) (the “Company” or “Integrated Cannabis”), is pleased to announce the completion of a market ready Tetrahydrocannabinol (THC)-infused spray product and the required licensure for manufacturing of the product in Colorado. Over the past ten months the Company has engaged and worked... Read more
InMed Pharmaceuticals Inc. (IMLFF) Reports Fourth Quarter and Full Year Fiscal 2018 Financial Results
InMed Pharmaceuticals Inc. (“InMed” or the “Company”) (TSX:IN; OTCQX:IMLFF), a fully integrated, cannabinoid-based biopharmaceutical company that leverages its proprietary platform technologies to develop novel therapeutics for the treatment of diseases with high unmet medical needs, today reported financial results for the three and twelve months ended June 30, 2018, which is... Read more
( ) ( ) ( ) ( ) ( ) ( ) ( ) ( )